Arcoma

Arcoma Equity Ratio

The Equity Ratio of Arcoma (ARCOMA.ST) as of Oct 24, 2026 is 77.32 %. In the previous year, Equity Ratio was 73.74 % — a change of 4.85% (higher).

Equity Ratio

77.32 %

YoY

4.85%

Last updated:

Equity Ratio of Arcoma is 2025 77.32 % . Equity Ratio of Arcoma was 2024 73.74 % . It decreases by 4.85% higher compared to the previous year.

The Arcoma Equity Ratio history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Equity Ratio
Date
Equity Ratio
Jan 1, 2018
51.18 SEK
Jan 1, 2019
54.23 SEK
Jan 1, 2020
52.12 SEK
Jan 1, 2021
55.56 SEK
Jan 1, 2022
45.72 SEK
Jan 1, 2023
59.37 SEK
Jan 1, 2024
73.74 SEK
Jan 1, 2025
77.32 SEK
The Arcoma Equity Ratio history
YEAREquity RatioYoY
77.32 %+4.85%
73.74 %+24.22%
59.37 %+29.84%
45.72 %-17.70%
55.56 %+6.59%
52.12 %-3.88%
54.23 %+5.96%
51.18 %-14.64%
59.95 %+14.38%
52.42 %-11.53%
59.25 %+12.47%
52.68 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Arcoma Stock analysis

What does Arcoma do? Arcoma AB generates revenue through the sale of its digital radiographic systems, which include complete systems like ceiling suspensions and floor-mounted units, as well as detectors and components such as overhead tube cranes and radiographic tables. The company markets its products under the IMIX brand, through private label distributors, and as original equipment manufacturer (OEM) solutions. Its primary customers are hospitals, clinics, imaging centers, and private practices seeking digital imaging technology with advanced mobile positioning systems. The Precision and Elite mobile imaging table series are key product offerings within its portfolio. The company's business model relies on direct sales of IMIX-branded systems to healthcare facilities, while also supplying components to private label distributors and OEM partners. These channels allow Arcoma to reach a broad range of healthcare providers across different segments. The firm's product range targets facilities requiring flexible, mobile imaging solutions for diagnostic procedures. Arcoma AB's revenue streams are derived from the sale of complete radiographic systems, system components, and mobile imaging tables, all designed for healthcare environments. The IMIX brand represents the company's direct-to-customer offering, while private label and OEM arrangements provide additional distribution pathways. The Precision and Elite series specifically cater to the needs of medical practices requiring mobile diagnostic equipment. Arcoma is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Arcoma stock

Equity Ratio of Arcoma is 77.32 % in 2025.

Equity Ratio of Arcoma changed from 73.74 % to 77.32 %, representing a 4.85% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Equity Ratio Arcoma since 2006 – with annual values, charts, and detailed analysis.

The equity ratio measures the proportion of total assets financed by shareholders' equity. Higher ratios indicate stronger financial independence and lower leverage.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Equity Ratio's Arcoma with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — Arcoma

All Key Metrics — Arcoma